Márquez L, Trapote M A, Luque M A, Valverde I, Villanueva-Peñacarrillo M L
Departamento Metabolismo Nutrición y Hormonas, Fundación Jiménez Díaz, Madrid, Spain.
Cell Biochem Funct. 1998 Mar;16(1):51-6. doi: 10.1002/(SICI)1099-0844(199803)16:1<51::AID-CBF767>3.0.CO;2-T.
Insulin-like effects of glucagon-like peptide-1(7-36)amide (GLP-1) in rat liver, skeletal muscle and fat, and also the presence of GLP-1 receptors in these extrapancreatic tissues, have been documented. In skeletal muscle and liver, the action of GLP-1 is not associated with an activation of adenylate cyclase, and in cultured murine myocytes and hepatoma cell lines, it was found that GLP-1 provokes the generation of inositolphosphoglycan molecules (IPGs), which are considered second messengers of insulin action. In the present work, we document in isolated normal rat adipocytes and hepatocytes that GLP-1 exerts a rapid decrease of the radiolabelled glycosylphosphatidylinositols (GPIs)--precursors of IPGs--in the same manner as insulin, indicating their hydrolysis and the immediate short-lived generation of IPGs. Thus, IPGs could be mediators in the GLP-1 actions in adipose tissue and liver, as well as in skeletal muscle, through GLP-1 receptors which are, at least functionally, different from that of the pancreatic B-cell.
胰高血糖素样肽-1(7-36)酰胺(GLP-1)在大鼠肝脏、骨骼肌和脂肪中的胰岛素样作用,以及这些胰腺外组织中GLP-1受体的存在,均已得到证实。在骨骼肌和肝脏中,GLP-1的作用与腺苷酸环化酶的激活无关,并且在培养的小鼠心肌细胞和肝癌细胞系中,发现GLP-1可引发肌醇磷酸聚糖分子(IPGs)的生成,这些分子被认为是胰岛素作用的第二信使。在本研究中,我们在分离的正常大鼠脂肪细胞和肝细胞中证明,GLP-1与胰岛素一样,能使放射性标记的糖基磷脂酰肌醇(GPIs)(IPGs的前体)迅速减少,这表明它们发生了水解并立即短暂生成了IPGs。因此,IPGs可能是GLP-1在脂肪组织和肝脏以及骨骼肌中发挥作用的介质,通过GLP-1受体介导,这些受体至少在功能上与胰腺β细胞的受体不同。